Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
VRCA

Market Cap: $84.35M

VI

Verrica Pharmaceuticals Inc.

VRCA

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin85.89%

EBITDA Margin-88.61%

EBIT Margin-90.53%

Pre-tax Margin-1.03%

Net Profit Margin-1.03%

Earnings Yield-29.81%

Valuation Multiples

Price / Book24.29

Price / Sales2.78

Price / Earnings-2.82

PEG-0.08

Forward PEG0.08

EV / Sales2.47

EV / EBITDA-2.79

EV / Operating Cash Flow-5.62

EV / Free Cash Flow-5.62

Price / Free Cash Flow-6.32

Price / Operating Cash Flow-7.84

Cash Flow & Capital

Free Cash Flow / Share-$0.63

Operating Cash Flow / Share-$0.63

Free Cash Flow Yield-15.82%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue11.59%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.45

Quick Ratio1.33

Cash Ratio0.50

Debt / Assets0.05

Debt / Capital0.30

Debt / Equity0.42

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.35

Solvency Ratio-0.96

Financial Leverage8.36

Efficiency & Working Capital

Asset Turnover0.84

Fixed Asset Turnover14.91

Inventory Turnover1.58

Receivables Turnover2.73

Payables Turnover2.67

Days Sales Outstanding133.5

Days Inventory Outstanding231.44

Days Payables Outstanding136.8

Operating Cycle364.94

Cash Conversion Cycle228.14

Working Capital Turnover2.27

Returns & Quality

Return on Equity-4.44%

Return on Assets-86.58%

Return on Invested Capital-1.94%

ROCE-2.07%

Return on Tangible Assets-86.58%

Operating Return on Assets-75.21%

Income Quality0.43

Tax Burden1.00

Interest Burden1.14

Balance Sheet & Intrinsic Metrics

Enterprise Value$74.96M

Invested Capital$12.23M

Working Capital$10.2M

Tangible Asset Value$4.31M

Net Current Asset Value$929K

Graham Net-Net-$0.51

Book Value / Share$0.2

Tangible Book Value / Share$0.2

Cash / Share$0.53

Financial Health Scores

Piotroski Score4

Altman Z-Score-13.25

Revenue$30.32M

EBIT$-27.45M

Market Cap$84.35M

Working Capital$10.2M

Retained Earnings$-347.75M

Total Assets$36.02M

Total Liabilities$31.71M